Lakewood, Colo. — October 3, 2025 — Leads & Copy — Mesa Laboratories, Inc. (NASDAQ:MLAB) will release its financial results for the second quarter of fiscal year 2026 after the market closes on Thursday, November 6, 2025.
Mesa Laboratories, Inc. is a global leader in designing and manufacturing life science tools and critical quality control solutions. These solutions cater to regulated applications within the pharmaceutical, healthcare, and medical device industries. Mesa’s products and services support customers in ensuring product integrity, enhancing patient and worker safety, and improving quality of life worldwide.
Contact: Gary Owens, President and CEO, or John Sakys, CFO, Mesa Laboratories, Inc., +1-303-987-8000
Source: Mesa Laboratories, Inc.
